Gsa Capital Partners LLP Ionis Pharmaceuticals Inc Transaction History

Gsa Capital Partners LLP

$1.32 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	SELL	$36.45 - $47.7 $3,426 - $4,483	-94 Reduced 1.13%	8,231 $392,000
Q1 2024 May 03, 2024	SELL	$42.03 - $53.55 $141,010 - $179,660	-3,355 Reduced 28.72%	8,325 $360,000
Q4 2023 Feb 16, 2024	BUY	$43.39 - $51.63 $506,795 - $603,038	11,680 New	11,680 $590,000
Q1 2023 May 12, 2023	BUY	$33.58 - $41.2 $316,390 - $388,186	9,422 New	9,422 $336,000
Q2 2022 Aug 09, 2022	BUY	$31.71 - $43.0 $173,612 - $235,425	5,475 New	5,475 $203,000
Q1 2022 May 11, 2022	SELL	$29.88 - $37.04 $399,435 - $495,150	-13,368 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$25.61 - $35.1 $342,354 - $469,216	13,368 New	13,368 $407,000
Q4 2020 Feb 03, 2021	SELL	$45.3 - $60.27 $717,642 - $954,797	-15,842 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$47.45 - $62.95 $751,702 - $997,253	15,842 New	15,842 $752,000
Q1 2020 May 12, 2020	SELL	$41.6 - $63.4 $261,580 - $398,659	-6,288 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$53.85 - $65.27 $338,608 - $410,417	6,288 New	6,288 $380,000
Q3 2019 Nov 12, 2019	SELL	$59.06 - $72.15 $1.16 Million - $1.42 Million	-19,690 Closed	0 $0
Q2 2019 Aug 06, 2019	BUY	$62.09 - $86.14 $284,993 - $395,382	4,590 Added 30.4%	19,690 $1.27 Million
Q1 2019 May 15, 2019	SELL	$52.92 - $81.17 $148,176 - $227,276	-2,800 Reduced 15.64%	15,100 $1.23 Million
Q4 2018 Feb 12, 2019	BUY	$43.37 - $59.54 $776,323 - $1.07 Million	17,900 New	17,900 $968,000
Q3 2018 Nov 13, 2018	SELL	$42.88 - $53.7 $1.38 Million - $1.73 Million	-32,200 Closed	0 $0
Q2 2018 Aug 09, 2018	SELL	$40.53 - $50.7 $932,190 - $1.17 Million	-23,000 Reduced 41.67%	32,200 $1.34 Million
Q1 2018 May 11, 2018	BUY	$44.08 - $55.05 $313,276 - $391,240	7,107 Added 14.78%	55,200 $2.43 Million
Q4 2017 Feb 14, 2018	BUY	$50.3 - $64.39 $1.22 Million - $1.56 Million	24,200 Added 101.28%	48,093 $2.42 Million
Q3 2017 Nov 20, 2017	BUY	$45.56 - $59.57 $1.09 Million - $1.42 Million	23,893	23,893 $1.21 Million

Others Institutions Holding IONS

# of Institutions

403

Shares Held

136M

Call Options Held

862K

Put Options Held

582K

Vanguard Group Inc Valley Forge, PA

15.1M
Shares

$567 Million
0.01% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

14.2M
Shares

$534 Million
0.34% of portfolio
Black Rock Inc. New York, NY

10.3M
Shares

$389 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

8.74M
Shares

$329 Million
0.06% of portfolio
Bellevue Group Ag Kuesnacht, V8

7.87M
Shares

$297 Million
5.32% of portfolio

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Account